section name header

Table 180-3

Indications for BMD Testing

  • Women aged 65 and men aged 70; regardless of clinical risk factors
  • Younger postmenopausal women, women in the menopausal transition, and men aged 50-69 with clinical risk factors for fracture
  • Adults who have a fracture at or after age 50
  • Adults with a condition (e.g., rheumatoid arthritis) or taking a medication (e.g., glucocorticoids at a daily dose >5 mg prednisone or equivalent for >3 months associated with low bone mass or bone loss)